Table 1 Demographic characteristics and statistical analysis.

From: Gut microbial biomarkers for the treatment response in first-episode, drug-naïve schizophrenia: a 24-week follow-up study

 

SCH patients (N = 107)

Healthy controls (N = 107)

Z, t, or X2 value

p value

Median (IOR)

Median (IOR)

Age (years)

19 (19–25)

23.00 (22.00–25.00)

1.642

0.103

Education years

12 (11–13)

12 (12–12)

−0.654

0.513

Body weight (kg)

58.6 (51–65)

57.15 (52.3–67.5)

−0.579

0.563

BMI (kg/m2)

20.71 (18.91–22.41)

21.17 (19.41–23.16)

−1.373

0.170

hs-CRP (mg/L)

0.28 (0.15–0.62)

0.20 (0.13–0.40)

−1.995

0.035

HCY (mmol/L)

14.81 (12.10–19.50)

10.45 (8.36–17.86)

−3.882

1.49 × 10−6

PANSS-FSPS

17.00 (13.75–19.00)

   

PANSS-FSNS

19.00 (14.75–23.00)

   

PANSS-G

39.00 (35.00–47.00)

   

PANSS-T

79.50 (72.00–89.25)

   

Disease duration

180 (30–365)

   

Gender

Male

51 (48)

37 (35)

3.783

0.071

Female

56 (52)

70 (65)

  

Smoking

Yes

5 (5%)

6 (6%)

0.096

0.500

No

102 (95%)

101 (94%)

  
  1. Note: Hs-CRP high-sensitivity C-reactive protein, HCY homocysteine, PANSS-FSPS PANSS factor score for positive symptoms, PANSS-FSNS PANSS factor score for negative symptoms, PANSS The Positive and Negative Syndrome Scale, including positive, negative, and general psychopathology symptoms represented by PANSS-P, PANSS-N, and PANSS-G, respectively, PANSS-T=PANSS-P+PANSS-N+PANSS-G, SCH schizophrenia.
Back to article page